This combination strategy increases DNA damage and blocks the repair process ... activity of PARPis with other cancer drugs like gemcitabine, cetuximab-monoclonal antibody, and vascular endothe ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback